Lunai Bioworks (LNAI) Notes Payables (2011 - 2025)
Lunai Bioworks (LNAI) recorded quarterly Notes Payables of $1.3 million in Q4 2025, up 20.38% quarter-over-quarter from $1.0 million in Q3 2025, and up 410.27% on a YoY basis from $245000.0 in Q4 2024.
Lunai Bioworks (LNAI) Notes Payables (2011 - 2025) Analysis & Trends
Lunai Bioworks' Notes Payables history runs 13 years deep, the most recent figure standing at $1.3 million for Q4 2025.
- In Q4 2025, Notes Payables rose 410.27% year-over-year to $1.3 million; the TTM figure through Dec 2025 stood at $1.3 million (up 410.27% YoY), while the FY2025 annual figure was $3.6 million, up 1361.44% from the prior year.
- Notes Payables was $1.3 million for Q4 2025 at Lunai Bioworks, up from $1.0 million in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $4.8 million in Q1 2022 to a low of $245000.0 in Q2 2024.
- Historically, Notes Payables has averaged $2.3 million across 5 years, with a median of $1.2 million in 2022.
- The sharpest annual moves came in 2023 and 2025: Notes Payables sank 75.01% in 2023, then surged 1361.44% in 2025.
- A 5-year view of Notes Payables shows it stood at $4.7 million in 2021, then retreated by 0.03% to $4.7 million in 2022, then plunged by 74.61% to $1.2 million in 2023, then sank by 79.58% to $245000.0 in 2024, then surged by 410.27% to $1.3 million in 2025.
- The last three Notes Payables figures came in at $1.3 million (Q4 2025), $1.0 million (Q3 2025), and $3.6 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Lunai Bioworks | 95.85 Mn | 92.70 Mn | 20,942.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.25 Mn |
| Sep 30, 2025 | 1.04 Mn |
| Jun 30, 2025 | 3.58 Mn |
| Mar 31, 2025 | 245,000.00 |
| Dec 31, 2024 | 245,000.00 |
| Sep 30, 2024 | 245,000.00 |
| Jun 30, 2024 | 245,000.00 |
| Mar 31, 2023 | 1.20 Mn |
| Dec 31, 2022 | 4.73 Mn |
| Sep 30, 2022 | 1.20 Mn |
| Jun 30, 2022 | 1.20 Mn |
| Mar 31, 2022 | 4.80 Mn |
| Dec 31, 2021 | 4.73 Mn |
| Jun 30, 2021 | 4.58 Mn |
| Mar 31, 2021 | 4.50 Mn |
| Dec 31, 2020 | 4.73 Mn |
| Sep 30, 2020 | 4.65 Mn |
| Dec 31, 2017 | 89,000.00 |
| Sep 30, 2017 | 88,408.00 |
| Jun 30, 2017 | 1.69 Mn |